TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27836508

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus (L. rhamnosus) HN001 probiotic treatment for 4 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 114
Study: 26163236

Group type: EXPERIMENTAL
Intervention: Topical mitomycin C (MMC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 30
Study: 23577900

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Oral naltrexone
Number of subjects: 7
Study: 21890526

Group type: EXPERIMENTAL
Intervention: Exercise (40 minutes, three times a week for 3 months)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Relaxation (recorded programme for 3 months)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Topiramate (daily use, titrated to maximum 200 mg/day for 3 months)
Number of subjects: 91
Study: 18974973

Group type: EXPERIMENTAL
Intervention: Group B (posterior-inferior capsular plications)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group A (no posterior-inferior capsular plications)
Number of subjects: 40
Study: 17453387

Group type: EXPERIMENTAL
Intervention: Fast-track program after total hip replacement
Number of subjects: 79

Group type: COMPARATOR
Intervention: Non-consenters (control group)
Number of subjects: 79
Study: 15047537

Group type: EXPERIMENTAL
Intervention: Artesunate alone
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Artesunate with primaquine
Number of subjects: 176

Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 176

Group type: COMPARATOR
Intervention: Quinine with primaquine at 15 mg/day
Number of subjects: 176

Group type: COMPARATOR
Intervention: Quinine with primaquine at 30 mg/day
Number of subjects: 176

Group type: COMPARATOR
Intervention: Quinine with tetracycline
Number of subjects: 176
Study: 11334202

Group type: EXPERIMENTAL
Intervention: Leukocyte-depleting filters (group F)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 40
Study: 9564064

Group type: EXPERIMENTAL
Intervention: 0.5% intraperitoneal subdiaphragmatic lidocaine 40 ml and 0.5% bupivacaine 5 ml infiltration of cannula insertion sites
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study: 7994223

Group type: EXPERIMENTAL
Intervention: Health education and counselling programme with telephone follow-up (experimental group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Health education and counselling programme with telephone follow-up (experimental group) with partner participation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard medical care only (control group)
Number of subjects: 60
Study: 2535450

Group type: EXPERIMENTAL
Intervention: Semi-elemental diets
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 32
Study: 31846575

Group type: EXPERIMENTAL
Intervention: venlafaxine extended release for 12 weeks
Number of subjects: 500
Study: 27871827

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 165

Group type: COMPARATOR
Intervention: Asymptomatic infection with Mycoplasma hominis
Number of subjects: 165
Study: 25594788

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23669885

Group type: EXPERIMENTAL
Intervention: SAMe-TT₂R₂ score = 0-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SAMe-TT₂R₂ score ≥ 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear regression model with nine independent predictors of TTR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: c-index of SAMe-TT₂R₂ score
Number of subjects: 0
Study: 21372034

Group type: EXPERIMENTAL
Intervention: SR13668 (38 mg oral dose)
Number of subjects: 20
Study: 19727884

Group type: EXPERIMENTAL
Intervention: Seal oil capsules (340 mg EPA, 230 mg DPA, 450 mg DHA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fish oil capsules (210 mg EPA, 30 mg DPA, 810 mg DHA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo capsules (containing sunola oil)
Number of subjects: 48
Study: 17387133

Group type: EXPERIMENTAL
Intervention: 40 mg/kg of reconstituted HDL (CSL‐111)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 183
Study: 15114551

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV) with volume guarantee (VG) (Vt = 5 ml/kg) (n = 30)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV) without volume guarantee (n = 23)
Number of subjects: 53
Study: 11605121

Group type: EXPERIMENTAL
Intervention: Ipratropiumbromide inhalation with RC-Cornet(R)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ipratropiumbromide inhalation with conventional inhalation (Pari-system)
Number of subjects: 35
Study: 7992674

Group type: EXPERIMENTAL
Intervention: Real smoking
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 15
Study: 2688737

Group type: EXPERIMENTAL
Intervention: Azathioprine 50 mg t.d.s.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1079213

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31741073

Group type: EXPERIMENTAL
Intervention: 4 mg of dexamethasone injected within 10 minutes of detected LOS in Group 2 (G2)
Number of subjects: 702

Group type: COMPARATOR
Intervention: No intervention in Group 1 (G1)
Number of subjects: 702
Study: 31870456

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (low frequency)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (high frequency)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (alternating frequency)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study: 28327695

Group type: EXPERIMENTAL
Intervention: Definitive abutment group (immediate loading)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Repeated abutment changes group (delayed loading)
Number of subjects: 80
Study: 25114060

Group type: EXPERIMENTAL
Intervention: Autologous adipose-derived stromal vascular fraction (SVF) injection
Number of subjects: 12
Study: 23569370

Group type: EXPERIMENTAL
Intervention: UMEC 500 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UMEC 500 μg/VI 25 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verapamil 240 mg (administered on days 9-13)
Number of subjects: 0
Study: 20331687

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Random transfusion
Number of subjects: 163

Group type: COMPARATOR
Intervention: No transfusion (Control)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Delayed graft function patients
Number of subjects: 163
Study: 19922877

Group type: EXPERIMENTAL
Intervention: Timolol in sorbate 0.5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Timolol gel-forming solution 0.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Timolol hemihydrate 0.5%
Number of subjects: 30
Study: 17124643

Group type: EXPERIMENTAL
Intervention: Hypericum extract WS 5570 (900 mg/d or 1800 mg/d)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Paroxetine (20 mg/d or 40 mg/d)
Number of subjects: 133
Study: 14704914

Group type: EXPERIMENTAL
Intervention: Test Product (HP-guar gellable lubricant eye drop)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control Product (carboxymethylcellulose)
Number of subjects: 87
Study: 11336121

Group type: EXPERIMENTAL
Intervention: Brief dental office-based intervention for smokeless tobacco users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief dental office-based intervention for smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Workshops for disseminating the smokeless tobacco intervention to DHCWs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-study for disseminating the smokeless tobacco intervention to DHCWs
Number of subjects: 0
Study: 9643220

Group type: EXPERIMENTAL
Intervention: Tretinoin (0.25 mg daily of 0.1% tretinoin cream)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-treated control
Number of subjects: 11
Study: 8360602

Group type: EXPERIMENTAL
Intervention: Electronic apex locator
Number of subjects: 26

Group type: COMPARATOR
Intervention: Radiographic method
Number of subjects: 26
Study: 2426902

Group type: EXPERIMENTAL
Intervention: Various established topical and systemic treatment regimes
Number of subjects: 20
Study: 31949084

Group type: EXPERIMENTAL
Intervention: GIP infusion (6 pmol/kg/min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (saline) infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: GIP infusion
Number of subjects: 22
Study: 29868449

Group type: EXPERIMENTAL
Intervention: Boosted acupuncture
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard acupuncture
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 74
Study: 26833397

Group type: EXPERIMENTAL
Intervention: Myofascial-meridian release acupuncture (MMRA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 74
Study: 25672194

Group type: EXPERIMENTAL
Intervention: Ketac Molar (GIC)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Vitremer (RMGIC)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both cements
Number of subjects: 27
Study: 22077106

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 650

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 650
Study: 21117361

Group type: EXPERIMENTAL
Intervention: Excimer laser phototherapeutic keratectomy (PTK)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Surgical keratectomy of ulcer edge and base (Control)
Number of subjects: 53
Study: 17331512

Group type: EXPERIMENTAL
Intervention: Tapered colonoscope (TC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pediatric variable‐stiffness colonoscope (PVSC)
Number of subjects: 40
Study: 16279889

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg combined with clarithromycin 500 mg and amoxicillin 1 g for 1 week
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg combined with clarithromycin 500 mg and amoxicillin 1 g for 1 week
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 12411798

Group type: EXPERIMENTAL
Intervention: Magnesium group (50 mg/kg as a bolus, then 8 mg x kg(‐1) x h(‐1))
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (0.9% sodium chloride solution)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Magnesium group (propofol infusion rate maintained at 80 microg x kg(‐1) x min(‐1))
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (propofol infusion rate maintained at 160 microg x kg(‐1) x min(‐1))
Number of subjects: 54
Study: 10470755

Group type: EXPERIMENTAL
Intervention: Traditional tidal volume ventilation (10-12 mL/kg ideal body weight)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Reduced tidal volume ventilation (5-8 mL/kg ideal body weight)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 7784000

Group type: EXPERIMENTAL
Intervention: Vitamin K and phenobarbital
Number of subjects: 372
Study: 1283851

Group type: EXPERIMENTAL
Intervention: Vinorelbine (single-agent)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Vinorelbine combined with cisplatin
Number of subjects: 153
Study: 3971659

Group type: EXPERIMENTAL
Intervention: Frusemide (6 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Frusemide with salt replacement
Number of subjects: 26
Study: 31335865

Group type: EXPERIMENTAL
Intervention: Adherence Clubs (ACs)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Decentralized Medication Delivery (DMD)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control (standard of care) for ACs
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control (standard of care) for DMD
Number of subjects: 507
Study: 29218411

Group type: EXPERIMENTAL
Intervention: Group 2 (with clinical information)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group 1 (without clinical information)
Number of subjects: 90
Study: 26887966

Group type: EXPERIMENTAL
Intervention: Tomato sauce enriched with refined olive oil (ROOE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tomato sauce without refined olive oil (oil-free: OF)
Number of subjects: 40
Study: 25576329

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 422

Group type: COMPARATOR
Intervention: Comparator OADs
Number of subjects: 422

Group type: COMPARATOR
Intervention: Both cohorts
Number of subjects: 422
Study: 23759203

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Flupentixol
Number of subjects: 31
Study: 19945297

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (TEA-B group, n = 13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (TEA-S group, n = 13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intravenous remifentanil (IV-R group, n = 13)
Number of subjects: 39
Study: 23344073

Group type: EXPERIMENTAL
Intervention: Intravenous administration of Prostaglandin E2 (250-500 µg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intramuscular administration of Prostaglandin E2 (250-500 µg)
Number of subjects: 50
Study: 16823366

Group type: EXPERIMENTAL
Intervention: Physical warm-up
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skill-specific warm-up
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skill plus physical warm-up
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 12
Study: 12522370

Group type: EXPERIMENTAL
Intervention: Combination of calcipotriene 50 microg/g and betamethasone dipropionate 0.5 mg/g in the new vehicle
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Calcipotriene in the new vehicle
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Betamethasone dipropionate in the new vehicle
Number of subjects: 1028

Group type: COMPARATOR
Intervention: New vehicle alone
Number of subjects: 1028
Study: 10917402

Group type: EXPERIMENTAL
Intervention: High-dose intravenous amitriptyline (150 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medium-dose intravenous amitriptyline (100 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral amitriptyline (150 mg/day)
Number of subjects: 80
Study: 8572635

Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 473

Group type: COMPARATOR
Intervention: Normal weight patients
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Patients with axillary lymph node involvement
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Patients without recurrence
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Patients with recurrent disease
Number of subjects: 473
Study: 2707124

Group type: EXPERIMENTAL
Intervention: bismuth subsalicylate, 1800 mg/d for four weeks
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: amoxycillin 2250 mg/d for two weeks
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg/d for four weeks
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: bismuth plus amoxycillin
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: bismuth plus ranitidine
Number of subjects: 302
Study: 99226

Group type: EXPERIMENTAL
Intervention: Adjuvant MOPP chemotherapy combined with radiotherapy
Number of subjects: 440

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Radiation therapy in chemotherapy management for stage IV patients
Number of subjects: 440
Study: 30371546

Group type: EXPERIMENTAL
Intervention: 45ICE (ice slurry ingestion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 45FL (tepid fluid ingestion)
Number of subjects: 8
Study: 28625658

Group type: EXPERIMENTAL
Intervention: Active high-frequency tRNS
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 2
Study: 26789997

Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 300 standard reactivity units (SRU) for 6 months
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 150 SRU for 6 months
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 50 SRU for 6 months
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Tolerability assessment of SLIToneULTRA® HDM mix
Number of subjects: 219
Study: 23200784

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification Treatment (ABMT) training towards happy faces
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) only
Number of subjects: 69

Group type: COMPARATOR
Intervention: Healthy comparison youth
Number of subjects: 69
Study: 21946915

Group type: EXPERIMENTAL
Intervention: Enoxaparin (prophylactic daily dose starting from the positive pregnancy test)
Number of subjects: 224
Study: 19192858

Group type: EXPERIMENTAL
Intervention: Higher probability of winning a prize
Number of subjects: 116

Group type: COMPARATOR
Intervention: Size of individual prizes (small, large, jumbo)
Number of subjects: 116
Study: 16508259

Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no dopamine treatment)
Number of subjects: 97
Study: 12540290

Group type: EXPERIMENTAL
Intervention: Cold saline (4 degrees C)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Warm saline (37 degrees C)
Number of subjects: 11
Study: 10898425

Group type: EXPERIMENTAL
Intervention: metoprolol CR/XL
Number of subjects: 394

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 394
Study: 8730159

Group type: EXPERIMENTAL
Intervention: Basic compounds with high pKa (e.g., mecamylamine, pKa = 11.2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Basic compounds with low pKa
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Basic compounds with varying pKa
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High pKa compounds
Number of subjects: 12
Study: 8103470

Group type: COMPARATOR
Intervention: Standard antiemetic regimen (control, n = 24)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (HDM, n = 33)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Very high dose metoclopramide (VHDM, n = 50)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Very high dose metoclopramide plus droperidol (VHDM+DP, n = 14)
Number of subjects: 121
Study: 3946262

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise training at home
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High-intensity exercise training at home
Number of subjects: 64

Group type: COMPARATOR
Intervention: Customary activity (Control)
Number of subjects: 64
Study: 29258678

Group type: EXPERIMENTAL
Intervention: ADF (alternate-day fasting)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CR (daily calorie restriction)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (100% of energy needs)
Number of subjects: 100
Study: 27008102

Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin-impregnated clothing
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 159
Study: 24346753

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DXM) 360 mg/d for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DXM) 360 mg/d
Number of subjects: 40
Study: 22872988

Group type: EXPERIMENTAL
Intervention: Head-down tilt (HDT) at -90 degrees
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Head-up tilt (HUT) at +90 degrees
Number of subjects: 21

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 21
Study: 20211025

Group type: EXPERIMENTAL
Intervention: Internet Support Group (ISG) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-module automated psychoeducational and skills Internet Training Program (ITP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ISG and ITP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internet Attention Control website (IAC)
Number of subjects: 0
Study: 18227297

Group type: EXPERIMENTAL
Intervention: Propofol/Remifentanil (group PR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam/Fentanyl (group MF)
Number of subjects: 50
Study: 16433405

Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol (ZOE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Calcicur
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vitapex
Number of subjects: 80
Study: 12598260

Group type: COMPARATOR
Intervention: IV saline (placebo group; n = 20)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: droperidol 1 mg (dro-1 group; n = 20)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: droperidol 2 mg (dro-2 group; n = 20)
Number of subjects: 80
Study: 10470576

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg per day for the first 3 days, 0.25 mg/kg per day for the next 3 days, 0.125 mg/kg per day on the 7th day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no steroid treatment)
Number of subjects: 50
Study: 8698957

Group type: EXPERIMENTAL
Intervention: Research engagement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term outcome
Number of subjects: 0
Study: 1667472

Group type: EXPERIMENTAL
Intervention: Pyrophosphate/Gantrez copolymer dentifrice
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Zinc citrate dentifrice
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 150
Study: 6336719

Group type: EXPERIMENTAL
Intervention: slow‐release metoprolol 200 mg once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: matched placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: slow‐release metoprolol
Number of subjects: 20